Authors:
Pallis, M
Turzanski, J
Harrison, G
Wheatley, K
Langabeer, S
Burnett, AK
Russell, NH
Citation: M. Pallis et al., Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia, BR J HAEM, 104(2), 1999, pp. 307-312
Authors:
Dorak, MT
Burnett, AK
Worwood, M
Sproul, AM
Gibson, BES
Citation: Mt. Dorak et al., The C282Y mutation of HFE is another male-specific risk factor for childhood acute lymphoblastic leukemia, BLOOD, 94(11), 1999, pp. 3957-3957
Authors:
Burnett, AK
Grimwade, D
Solomon, E
Wheatley, K
Goldstone, AH
Citation: Ak. Burnett et al., Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Result of the randomized MRC trial, BLOOD, 93(12), 1999, pp. 4131-4143
Authors:
Mills, KI
Woodgate, LJ
Gilkes, AF
Walsh, V
Sweeney, MC
Brown, G
Burnett, AK
Citation: Ki. Mills et al., Inhibition of mitochondrial function in HL60 cells is associated with an increased apoptosis and expression of CD14, BIOC BIOP R, 263(2), 1999, pp. 294-300
Authors:
Mills, KI
Gilkes, AF
Sweeney, M
Choudhry, MA
Woodgate, LJ
Bunce, CM
Brown, G
Burnett, AK
Citation: Ki. Mills et al., Identification of a retinoic acid responsive aldoketoreductase expressed in HL60 leukaemic cells, FEBS LETTER, 440(1-2), 1998, pp. 158-162